A detailed history of Jane Street Group, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 24,135 shares of IGMS stock, worth $157,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,135
Previous 13,743 75.62%
Holding current value
$157,118
Previous $94,000 324.47%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.28 - $17.68 $65,261 - $183,730
10,392 Added 75.62%
24,135 $399,000
Q2 2024

Aug 14, 2024

SELL
$6.51 - $11.47 $113,124 - $199,314
-17,377 Reduced 55.84%
13,743 $94,000
Q1 2024

May 15, 2024

SELL
$8.68 - $17.36 $39,190 - $78,380
-4,515 Reduced 12.67%
31,120 $300,000
Q4 2023

Feb 14, 2024

BUY
$3.94 - $8.79 $140,401 - $313,231
35,635 New
35,635 $296,000
Q1 2023

May 15, 2023

BUY
$13.74 - $25.76 $187,276 - $351,108
13,630 New
13,630 $187,000
Q2 2022

Aug 16, 2022

BUY
$13.27 - $25.5 $266,859 - $512,805
20,110 New
20,110 $363,000
Q4 2021

Feb 15, 2022

SELL
$27.59 - $66.39 $598,923 - $1.44 Million
-21,708 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$65.76 - $90.65 $965,554 - $1.33 Million
14,683 Added 209.01%
21,708 $1.43 Million
Q1 2021

May 18, 2021

BUY
$71.56 - $121.23 $231,425 - $392,057
3,234 Added 85.31%
7,025 $539,000
Q3 2020

Nov 17, 2020

SELL
$43.0 - $84.01 $109,005 - $212,965
-2,535 Reduced 40.07%
3,791 $280,000
Q2 2020

Aug 17, 2020

BUY
$51.3 - $75.21 $324,523 - $475,778
6,326 New
6,326 $462,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $189M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.